Article
Exercise knowledge, barriers and motivators among LRRK2 G2019S mutation carriers.
Parkinsonism & related disorders - 1 Aug 2023
Schootemeijer S, Coker D, Shelton J F, Chanoff E, Rowbotham H M, Darweesh S K L, Bloem B R, Cannon P, de Vries N M
Abstract excerpt
INTRODUCTION: People with a Gly2019Ser mutation in the leucine-rich repeat kinase 2 (LRRK2 G2019S) are at increased risk of developing Parkinson's disease (PD). Recent evidence suggests that exercise may delay or prevent the development of clinically overt symptoms of PD in people at risk of PD. We determined whether LRRK2 G2019S mutation carriers with and without manifest PD are aware of the relationship between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.